Company Filing History:
Years Active: 2003-2008
Title: Innovations of Michael Power in Alzheimer's Research
Introduction
Michael Power is a notable inventor based in Fremont, CA, who has made significant contributions to the field of neurodegenerative disease research. He holds a total of nine patents, focusing primarily on the development of enzyme compositions that play a crucial role in understanding and potentially treating Alzheimer's disease.
Latest Patents
Among his latest patents, Michael Power has developed compositions and methods involving the β-secretase enzyme. This enzyme is known to be active and isolated in both purified and recombinant forms. It is implicated in the production of amyloid plaque components that accumulate in the brains of individuals afflicted with Alzheimer's disease. His patents disclose recombinant cells that produce this enzyme, either alone or in combination with its natural substrates, such as APP and APPsw. These compositions are instrumental in selecting compounds that modulate β-secretase, with inhibitors of this enzyme being considered as potential therapeutics for neurodegenerative diseases.
Career Highlights
Michael Power is currently associated with Elan Pharmaceuticals, Inc., where he continues to innovate in the field of Alzheimer's research. His work has been pivotal in advancing the understanding of β-secretase and its implications in neurodegenerative diseases.
Collaborations
Michael collaborates with esteemed colleagues, including John P. Anderson and Guriqbal Basi, to further enhance the research and development of therapeutic solutions for Alzheimer's disease.
Conclusion
Michael Power's innovative work in enzyme compositions and methods has the potential to significantly impact the treatment of Alzheimer's disease. His contributions to the field are invaluable and highlight the importance of continued research in neurodegenerative diseases.